Using Genetics to Prevent & Treat Pediatric Cancer скачать в хорошем качестве

Using Genetics to Prevent & Treat Pediatric Cancer

After decades of clinical breakthroughs, Dana-Farber has helped increase survival rates and new treatment options for children with cancer. Yet, childhood cancer is still the leading cause of disease-related death in children in the United States. To help overcome this challenge, Dana-Farber’s Pediatric Cancer Genetic Risk Program brings together a team of physicians, genetic counselors, and researchers to help manage all aspects of genetic cancer risk. Introduction by: Scott Armstrong, MD, PhD, President, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute, David G. Nathan Professor of Pediatrics, Harvard Medical School Panel: Lisa Diller, MD, Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute Co-Director, Pediatric Cancer Genetic Risk Program, Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center Director, David B. Perini Jr. Quality of Life Clinic for Childhood Cancer Survivors, Dana-Farber Cancer Institute; Junne Kamihara, MD, PhD, Physician, Dana-Farber Cancer Institute, Co-Director, Pediatric Cancer Genetic Risk Program; Jaclyn Schienda, ScM, LGC, Senior Genetic Counselor, Dana-Farber Cancer Institute